{Reference Type}: Journal Article
{Title}: COVID-19 induced type 1 diabetes: A systematic review of case reports and series.
{Author}: Stathi D;Triantafyllidis KK;Zafeiri M;Karalliedde J;Kechagias KS;
{Journal}: J Int Med Res
{Volume}: 51
{Issue}: 11
{Year}: 2023 Nov
{Factor}: 1.573
{DOI}: 10.1177/03000605231210403
{Abstract}: <B>OBJECTIVE: </B>To provide an overview of reported cases of new-onset type 1 diabetes mellitus (T1D) following COVID-19 infection.<BR><B>METHODS: </B>PubMed and Scopus library databases were screened for relevant case reports published between January 2020 and June 2022. Study design, geographic region or language were not restricted.<BR><B>RESULTS: </B>Twenty studies were identified and involved 37 patients (20 [54%] male, 17 [46%] female). Median age was 11.5 years (range 8 months-33 years) and 31 (84%) patients were aged ≤17 years. Most patients (33, 89%) presented with diabetic ketoacidosis (DKA). In total, 23 (62%) patients presented at the time of positive COVID-19 testing and 14 (38%) had symptoms consistent with COVID-19 infection or a previous positive test (1-56 days). Diabetes symptomatology was provided in 22 cases and (19, 86%) reported polyuria, polydipsia, polyphagia, fatigue, or weight loss or a combination of the aforementioned in the preceding weeks (3 days-12 weeks). Of the 28 patients that had data on acute and long-term treatment, all recovered well and most were managed with basal bolus insulin regimens. Quality assessment showed that most reports were either 'good' or 'moderate quality'.<BR><B>CONCLUSIONS: </B>Although uncommon, new-onset T1D is a condition healthcare professionals may expect to see following a COVID-19 infection.